Hillan Kenneth J. 4
4 · 23andMe Holding Co. · Filed Nov 22, 2022
Insider Transaction Report
Form 4
Hillan Kenneth
Head of Therapeutics
Transactions
- Tax Payment
Class A Common Stock
2022-11-20$2.99/sh−4,628$13,838→ 197,162 total
Footnotes (2)
- [F1]The closing price on November 18, 2022, the fair market used for the transaction date.
- [F2]Includes 5,707 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on August 31, 2022.